Clinical trial Recruiting at 3 sites Interventional Ages 7 to 15

Evaluating probiotics for autism symptoms and quality of life in children

Official title: The Effect of a Multispecies Probiotics on Autism Symptoms in Children

Run by Medical University of Warsaw · NCT06448767 · Data updated 2026-11-12

This study is testing if a special probiotic can help improve autism symptoms and quality of life for children aged 7 to 15 with Autism Spectrum Disorder.

More Autism Spectrum Disorder trials

Quick facts

Study typeInterventional
Ages7 Years to 15 Years
SexAll
Enrollment110 (estimated)
SponsorMedical University of Warsaw
Academic / other
Locations3 sites (Warsaw, Warsaw and 2 other locations)
StatusRecruiting
StartedAugust 7, 2024
Main results expectedJuly 2026
Study endsJuly 30, 2026
Registry record updatedJanuary 8, 2026
Trial IDNCT06448767 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 7 to 15 with a diagnosis of Autism Spectrum Disorder who meet specific inclusion criteria.

Probably not a fit

Patients who have recently used antibiotics or probiotics, have severe immunodeficiency, or have a history of intolerance to probiotics may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of a multispecies probiotic on children aged 7 to 15 diagnosed with Autism Spectrum Disorder (ASD). In a randomized, double-blind, placebo-controlled design, 108 participants will receive either the probiotic or a placebo for 12 weeks. The study aims to assess core autism symptoms and quality of life using validated questionnaires, alongside secondary outcomes related to sleep, parental stress, gastrointestinal symptoms, and urinary p-cresol levels. Assessments will occur at baseline and after the intervention period to evaluate changes in these outcomes.

Why it matters

Potential benefit: If successful, this study could provide a novel therapeutic option to improve autism symptoms and enhance the quality of life for affected children.

How similar studies have gone: While the use of probiotics in autism is an emerging area, previous studies have shown promising results, suggesting potential benefits in similar approaches.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosis of ASD according to the Diagnostic and Statistical Manual of Mental Disorders, the fifth edition (DSM-5) or International Classification of Diseases, Tenth Revision (ICD-10).
2. Children either not taking any medication or receiving the same medication for the last 2 months.
3. Patients, or their parents/caregivers, are willing to provide written informed consent, proceed with nutritional supplements throughout the 3-month trial, refrain from starting any kind of special diet for the duration of the study, and complete the questionnaires at two time points during the study.

Exclusion Criteria:

1. Use of antibiotics in the previous 2 months before enrolling (excluding topical antibiotics).
2. Use of probiotics or synbiotics within the previous 2 months.
3. History of intolerance or allergy to probiotics, synbiotics or any other study product component.
4. Surgery with bowel resection or short bowel syndrome.
5. Children with severe immunodeficiency.

Where it's running

  • Department of Paediatrics, The Medical University of Warsaw
    Warsaw, Warsaw, Poland
    Recruiting
  • Department of Paediatrics, The Medical University of Warsaw
    Warsaw, Warsaw, Poland
    Recruiting
  • Department of Paediatrics, The Medical University of Warsaw
    Warsaw, Warsaw, Poland
    Recruiting

Study contacts

  • Principal investigator: Maja Kotowska, MD — Department of Paediatrics, The Medical University of Warsaw, Poland
  • Study coordinator: Maja Kotowska, MD
  • Email: kotowska.maja@gmail.com
  • Phone: +48223179536

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.